<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04206748</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-19-0402</org_study_id>
    <nct_id>NCT04206748</nct_id>
  </id_info>
  <brief_title>iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes</brief_title>
  <acronym>iGlucose</acronym>
  <official_title>iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes: a Pilot Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Smart Meter Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether automation of glucose monitoring data to
      facilitate the total number of recommended and completed SMBG checks improve clinical
      outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a
      RCT
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 12, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 12, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neonatal morbidity</measure>
    <time_frame>at the time of discharge (about 2-7 days after birth)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neonatal gestational age at delivery</measure>
    <time_frame>at delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure># of neonates who where Small for gestational age (SGA)</measure>
    <time_frame>at delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neonatal intensive care unit (NICU) length of stay</measure>
    <time_frame>delivery to discharge (2-7 days)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure># of Neonates with hyperbilirubinemia-requiring therapy.</measure>
    <time_frame>delivery to discharge (2-7 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average Neonatal Weight</measure>
    <time_frame>at the time of discharge (about 2-7 days after birth)</time_frame>
    <description>To evaluate the relationship of change in average neonatal weight to two skill sets of Self-monitoring of blood glucose (SMBG), operational and interpretive, as demonstrated by patient-perceived self-efficacy and adherence to self-care behaviors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Mean fasting glucose</measure>
    <time_frame>perinatal to postpartum (32 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Mean post prandial glucose</measure>
    <time_frame>perinatal to postpartum (32 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal # of Hypoglycemia events (&lt;60 mg/dl)</measure>
    <time_frame>perinatal to postpartum (32 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal weight gain during pregnancy</measure>
    <time_frame>perinatal to postpartum (32 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Gestational hypertension</measure>
    <time_frame>perinatal to postpartum (32 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Preeclampsia</measure>
    <time_frame>perinatal to postpartum (32 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Cesarean delivery</measure>
    <time_frame>at delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Operative vaginal delivery</measure>
    <time_frame>at delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of SMBG checks on pregnancy</measure>
    <time_frame>perinatal to postpartum (32 weeks)</time_frame>
    <description>To evaluate relationship between percent of total achieved SMBG checks, diabetes distress, and maternal and neonatal outcomes, for women living with GDM and T2DM during pregnancy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gestational Diabetes</condition>
  <condition>Type2 Diabetes</condition>
  <condition>Pregnancy in Diabetic</condition>
  <arm_group>
    <arm_group_label>iGlucose Smart Meter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Rx glucose meter</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iGlucose Smart Meter System</intervention_name>
    <description>Subjects will have routine care enhanced by use of theThe iGlucose Smart meter system. This is an example of integration of a SMBG system with internet-based technology; including cell phone notifications for reminders, feedback, and communication with clinicians</description>
    <arm_group_label>iGlucose Smart Meter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Routine Care-RX meter</intervention_name>
    <description>Subjects will receive routine care with the insurance prescribed glucose meter. They will self manage with traditional diabetes diary.</description>
    <arm_group_label>Rx glucose meter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  All patients &gt;/= women 18 years of age with gestational diabetes or type 2 diabetes
             during pregnancy and identified by the research team and consented before 30.6 weeks.

          -  Non-anomalous singletons

          -  Ability to provide informed consent

        Exclusion Criteria

          -  Patients with Type 1 diabetes

          -  Patients with fetal major congenital abnormalities

          -  Patients identified/referred after 30.6 weeks
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joycelyn Corthwaite, RD</last_name>
    <phone>832-325-7205</phone>
    <email>joycelyn.a.cornthwaite@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clara Ward, MD</last_name>
    <phone>713-500-6412</phone>
    <email>clara.ward@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joycelyn Cornthwaite, RD</last_name>
      <phone>832-325-7205</phone>
      <email>joycelyn.a.cornthwaite@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sunbola Ashimi, PhD</last_name>
      <phone>713-500-6410</phone>
      <email>sunbola.s.ashimi@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 15, 2019</study_first_submitted>
  <study_first_submitted_qc>December 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Joycelyn Ashby Cornthwaite</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Pregnancy in Diabetics</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

